Home » Newsletters » BioWorld Asia

BioWorld Asia

Oct. 13, 1999

View Archived Issues

New European Commission Structure Leaves Questions

U.S. FDA Gives First-Ever Approval To Proneuron For Spinal Cord Cell Therapy Test

UK Researchers Show Drug Reduces Tumor Blood Flow

Trials Begin For Bayer's 1st German Biotech Product

Chemunex Launches New Test For E. Coli In Drinking Water

Focus On New Peptide Could Herald Lifetime Flu Vaccine

NicOx Launches $34M IPO To Speed Up Its R&D Efforts

MediGene In-Licenses Its Phase II-Ready CHF Drug

Alchemia To Build Pilot Plant For Carbohydrate Production

Genetically Modified Tomato Gets 'Amber Light' From EU

Other News To Note

European Biotech Community Denounces

Inpharmatica Unveils Database On Structure-Function Relationships

VitaResc Extends Product Pipeline With SIRS Drug

Genset Finds Schizophrenia Gene Through Janssen Collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...